Dermatologic Common (1% to 10%): Hair loss, rash, urticaria Postmarketing reports : Alopecia, angioedema, rash, urticaria Hair loss was reported in up to 5.8% of treated patients vs 1% placebo, with higher incidence associated with greater weight loss (20% or more)
Cambios en el estilo de vida junto con semaglutida Para que la semaglutida ofrezca los mejores resultados, se necesita una estrategia integral
Common gastrointestinal adverse effects include nausea (reported in approximately 44% of patients in clinical trials), vomiting, diarrhoea, and constipation, particularly during dose escalation
Canadian patients have been tracking these developments through resources like our generic semaglutide tracker, as generic versions are expected to significantly reduce current pricing of CAD $300-400 monthly for brand-name products